We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$701K
Cap. Flow
-$16.4M
Cap. Flow %
-8.91%
Top 10 Hldgs %
51.23%
Holding
107
New
12
Increased
18
Reduced
32
Closed
25

Top Buys

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$1.89M
2
BABA icon
Alibaba
BABA
+$1.31M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.09M
4
LFCR icon
Lifecore Biomedical
LFCR
+$965K
5
YETI icon
Yeti Holdings
YETI
+$443K

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$2.33M
2
ABBV icon
AbbVie
ABBV
+$1.75M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$1.28M
4
T icon
AT&T
T
+$1M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$986K

Sector Composition

Rank Sector Weight
1 Healthcare 32.01%
2 Technology 17.2%
3 Communication Services 6.8%
4 Consumer Discretionary 4.09%
5 Financials 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
101
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-5,000
Closed -$2.14M
VIR icon
102
Vir Biotechnology
VIR
$1.46B
– –
-10,000
Closed -$93.7K
WOLF icon
103
PUT
Wolfspeed
WOLF
$1.23B
– –
-4,000
Closed -$152K
XBI icon
104
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-13,500
Closed -$986K
IMPL
105
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
– –
-178,500
Closed -$76.8K
SGEN
106
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-11,000
Closed -$2.33M
1 2 3 4
5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, DCF Advisers held 107 positions worth $184M, up 0.38% from $184M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

DCF Advisers withdrew a net $16.4M in Q4 2023, closing 25 positions and reducing 32 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $2.33M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Yeti Holdings worth $518K.

  • DCF Advisers's largest Q4 2023 buy was Yeti Holdings: 10,000 shares worth $518K.
  • DCF Advisers added most to Revance Therapeutics, Inc. in Q4 2023, an estimated $1.89M increase.
  • DCF Advisers's biggest Q4 2023 reduction was AbbVie, cutting an estimated $1.75M.
  • DCF Advisers fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $2.33M.
  • DCF Advisers's ten largest holdings make up 51% of its $184M portfolio in Q4 2023.
  • DCF Advisers opened 12 new positions and closed 25 in Q4 2023.
  • DCF Advisers's portfolio value rose 0.38% quarter-over-quarter to $184M.

Based on DCF Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.